First Defense Manufacturing Gets $3.5M Boost from ImmuCell
ICCC has more than doubled off its 52-week low of $4.52.
Summary
ImmuCell Corporation authorized a $3.5 million Phase One expansion to significantly boost manufacturing capacity for its First Defense product line. This investment, which includes renovating a facility and adding a higher-capacity freeze dryer, is expected to take approximately 12 months. The decision follows an 8-K filed earlier today and comes after the company reported strong Q1 2026 product sales, up 28.4% year-over-year. This material capital expenditure signals management's confidence in the continued growth and demand for its key product.
At the time of this announcement, ICCC was trading at $9.67 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $87.5M. The 52-week trading range was $4.52 to $10.75. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.